Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Nicola Mongelli
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Concepts & Ideas
Anatomy
Disorders
Procedures
Sign-in to see full Profile
Network (preview)
14
Cozzi, Paolo
12
Geroni, Cristina
10
Romagnoli, Romeo
10
Baraldi, Pier Giovanni
8
Spalluto, Giampiero
6
D'Incalci, Maurizio
5
Capolongo, L
5
Gambari, Roberto
5
Cacciari, Barbara
5
Beria, Italo
5
Bianchi, Nicoletta
4
Broggini, Massimo
4
Caldarelli, Marina
3
Guiotto, Andrea
3
Mantovani, Roberto
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Nicola Mongelli (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2004: Beria Italo; Baraldi Pier Giovanni; Cozzi Paolo; Caldarelli Marina; Geroni Cristina; Marchini Sergio; Mongelli Nicola; Romagnoli Romeo
Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
Journal of medicinal chemistry 2004;47(10):2611-23.
-
2004: Cozzi Paolo; Mongelli Nicola; Suarato Antonino
Recent anticancer cytotoxic agents.
Current medicinal chemistry. Anti-cancer agents 2004;4(2):93-121.
-
2002: Beria Italo; Caldarelli Marina; Geroni Cristina; Mongelli Nicola; Reinach Benedetta; Vignati Luisella; Cozzi Paolo
Cytotoxic alpha-bromoacrylic derivatives of low molecular weight.
Bioorganic & medicinal chemistry letters 2002;12(11):1467-71.
-
2000: Baraldi P G; Romagnoli R; Beria I; Cozzi P; Geroni C; Mongelli N; Bianchi N; Mischiati C; Gambari R
Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
Journal of medicinal chemistry 2000;43(14):2675-84.
-
2000: Cozzi P; Beria I; Caldarelli M; Geroni C; Mongelli N; Pennella G
Cytotoxic alpha-bromoacrylic derivatives of distamycin analogues modified at the amidino moiety.
Bioorganic & medicinal chemistry letters 2000;10(11):1273-6.
-
2000: Cozzi P; Beria I; Caldarelli M; Capolongo L; Geroni C; Mongelli N
Cytotoxic halogenoacrylic derivatives of distamycin A.
Bioorganic & medicinal chemistry letters 2000;10(11):1269-72.
-
2000: Baraldi P G; Romagnoli R; Spalluto G; Cozzi P; Mongelli N; Bianchi N; Gambari R
DNA sequence-recognizing properties of minor groove alkylating agents. Effects of the replacement of N-methylpyrrole by an N-methylimidazole on tallimustine and its own homologue.
Arzneimittel-Forschung 2000;50(3):309-15.
-
1999: Baraldi P G; Balboni G; Romagnoli R; Spalluto G; Cozzi P; Geroni C; Mongelli N; Rutigliano C; Bianchi N; Gambari R
PNU 157977: a new potent antitumour agent exhibiting low in vivo toxicity in mice injected with L1210 leukaemia cells.
Anti-cancer drug design 1999;14(1):71-6.
-
1999: Baraldi P G; Cozzi P; Geroni C; Mongelli N; Romagnoli R; Spalluto G
Novel benzoyl nitrogen mustard derivatives of pyrazole analogues of distamycin A: synthesis and antileukemic activity.
Bioorganic & medicinal chemistry 1999;7(2):251-62.
-
1998: Baraldi P G; Cacciari B; Guiotto A; Leoni A; Romagnoli R; Spalluto G; Mongelli N; Howard P W; Thurston D E; Bianchi N; Gambari R
Design, synthesis and biological activity of a pyrrolo [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid.
Bioorganic & medicinal chemistry letters 1998;8(21):3019-24.
-
1998: Cozzi P; Mongelli N
Cytotoxics derived from distamycin A and congeners.
Current pharmaceutical design 1998;4(3):181-201.
-
1997: Baraldi P G; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid A N; Capolongo L; Cozzi P; Geroni C; Mongelli N
Synthesis, solvolytic stability and cytotoxicity of a modified derivative of CPzI, a pyrazole analog of the alkylation subunit of the antitumor agent CC-1065: effect of the nitrogen substitution on the functional reactivity.
Farmaco (Società chimica italiana : 1989) 1997;52(12):717-23.
-
1997: Baraldi P G; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid A N; Cozzi P; Geroni C; Mongelli N
Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activity.
Farmaco (Società chimica italiana : 1989) 1997;52(12):711-6.
-
1997: Baraldi P G; Cacciari B; Romagnoli R; Spalluto G; Gambari R; Bianchi N; Passadore M; Ambrosino P; Mongelli N; Cozzi P; Geroni C
Synthesis, cytotoxicity, antitumor activity and sequence selective binding of two pyrazole analogs structurally related to the antitumor agents U-71,184 and adozelesin.
Anti-cancer drug design 1997;12(7):555-76.
-
1997: Baraldi P G; Cacciari B; Pineda de las Infantas M J; Romagnoli R; Spalluto G; Cozzi P; Mongelli N
Synthesis, chemical solvolytic stability and preliminary biological evaluation of (+/-)-N-Boc-CPzI: a pyrazole analog of the left-hand segment of the antitumor agent CC-1065.
Anti-cancer drug design 1997;12(1):67-74.
-
1996: Popolo L; Viganò F; Erba E; Mongelli N; D'Incalci M
Effects of a novel DNA-damaging agent on the budding yeast Saccharomyces cerevisiae cell cycle.
Yeast (Chichester, England) 1996;12(4):349-59.
-
1995: Ronchi A; Bellorini M; Mongelli N; Mantovani R
CCAAT-box binding protein NF-Y (CBF, CP1) recognizes the minor groove and distorts DNA.
Nucleic acids research 1995;23(22):4565-72.
-
1995: Clanton D J; Buckheit R W; Terpening S J; Kiser R; Mongelli N; Borgia A L; Schultz R; Narayanan V; Bader J P; Rice W G
Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV.
Antiviral research 1995;27(4):335-54.
-
1995: Bellorini M; Moncollin V; D'Incalci M; Mongelli N; Mantovani R
Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription.
Nucleic acids research 1995;23(10):1657-63.
-
1995: Broggini M; Coley H M; Mongelli N; Pesenti E; Wyatt M D; Hartley J A; D'Incalci M
DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin.
Nucleic acids research 1995;23(1):81-7.
-
1995: Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Invasion & metastasis 1995;15(5-6):222-31.
-
1995: Sola F; Farao M; Pesenti E; Marsiglio A; Mongelli N; Grandi M
Antitumor activity of FCE 26644 a new growth-factor complexing molecule.
Cancer chemotherapy and pharmacology 1995;36(3):217-22.
-
1994: Ciomei M; Pastori W; Mariani M; Sola F; Grandi M; Mongelli N
New sulfonated distamycin A derivatives with bFGF complexing activity.
Biochemical pharmacology 1994;47(2):295-302.
-
1994: Mariani M; Capolongo L; Suarato A; Bargiotti A; Mongelli N; Grandi M; Beck W T
Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDR.
Investigational new drugs 1994;12(2):93-7.
-
1993: Capolongo L; Melegaro G; Broggini M; Mongelli N; Grandi M
Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).
British journal of cancer 1993;68(5):916-9.
-
1993: Coley H M; Mongelli N; D'Incalci M
The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
Biochemical pharmacology 1993;45(3):619-26.
-
1993: Geroni C; Pesenti E; Tagliabue G; Ballinari D; Mongelli N; Broggini M; Erba E; D'Incalci M; Spreafico F; Grandi M
Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies.
International journal of cancer. Journal international du cancer 1993;53(2):308-14.
-
1992: Pesenti E; Sola F; Mongelli N; Grandi M; Spreafico F
Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity.
British journal of cancer 1992;66(2):367-72.
-
1992: Sola F; Biasoli G; Pesenti E; Farao M; Della Torre P; Mongelli N; Grandi M
In vivo activity of novel sulphonic derivatives of distamycin A.
EXS 1992;61():459-62.
-
1992: Mariani M; Paio A; Ciomei M; Pastori W; Franzetti C; Melegaro G; Grandi M; Mongelli N
In vitro activity of novel sulphonic derivatives of distamycin A.
EXS 1992;61():455-8.
-
1991: Pezzoni G; Grandi M; Biasoli G; Capolongo L; Ballinari D; Giuliani F C; Barbieri B; Pastori A; Pesenti E; Mongelli N
Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.
British journal of cancer 1991;64(6):1047-50.
-
1989: Arcamone F M; Animati F; Barbieri B; Configliacchi E; D'Alessio R; Geroni C; Giuliani F C; Lazzari E; Menozzi M; Mongelli N
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.
Journal of medicinal chemistry 1989;32(4):774-8.
-
1989: Broggini M; Ponti M; Ottolenghi S; D'Incalci M; Mongelli N; Mantovani R
Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements.
Nucleic acids research 1989;17(3):1051-9.
Sign-in to see more
